Drug-coating Balloon Treatment in Coronary Artery Disease

Recruiting now

Conditions studied: Coronary Artery Disease

In brief

Drug-coated balloon (DCB) is an alternative choice for patients with coronary artery disease (CAD). This study is to investigate the efficacy and safety of DCB treatment in patients with CAD.

Key facts

Study ID

NCT04255563

Run by

Nanjing First Hospital, Nanjing Medical University

People needed

3000

Starts

2020-02-25

Expected to finish

2030-12-30

Last updated by the study team

2024-11-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients suitable for DCB treatment

You may not qualify if…

• Pregnancy
• Contraindications to contrast media, antiplatelet therapy, or paclitaxel
• Expected life less than 12 months
• Cardiac shock

Where it is running

• Nanjing First Hospital — Nanjing, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.